No, patients do not need to hold aspirin before cataract surgery
Patients should continue their aspirin therapy through cataract surgery without interruption. This recommendation applies to both low-dose (81 mg) and standard-dose aspirin regimens used for cardiovascular protection.
Guideline-Based Recommendation
The American College of Chest Physicians (ACCP) evidence-based guidelines explicitly recommend continuing aspirin around the time of cataract surgery rather than stopping it 7-10 days before the procedure 1. This applies specifically to patients receiving aspirin for secondary prevention of cardiovascular disease. The guideline categorizes cataract surgery as a low-bleeding-risk procedure where the minimal risk of ocular hemorrhage does not justify the thromboembolic risk of aspirin discontinuation.
Supporting Evidence on Safety
The most comprehensive recent meta-analysis of 65,196 patients confirms this approach 2. While aspirin continuation does increase the risk of subconjunctival hemorrhage (a benign, self-limited condition), it critically does not increase the risk of sight-threatening complications including:
- Hyphema
- Retrobulbar hemorrhage
- Vitreous hemorrhage
- Posterior capsule rupture
- Visual acuity changes
A large prospective cohort study of 19,283 cataract surgeries found that thromboembolic events (stroke, TIA, deep vein thrombosis) occurred at a rate of 3.8 per 1,000 surgeries in patients who continued aspirin, compared to only 1 per 1,000 in those who discontinued it 3. The absolute risk of serious ophthalmic bleeding remained extremely low regardless of aspirin use.
Clinical Algorithm
For all patients on aspirin undergoing cataract surgery:
- Continue aspirin - Do not interrupt therapy
- Use topical or intracameral anesthesia - Avoid needle-based regional blocks which carry higher bleeding risk 4
- Prefer clear corneal incisions - This technique minimizes bleeding risk 5
- Counsel patients - Warn about increased subconjunctival hemorrhage risk (cosmetic only, resolves spontaneously)
Key Pitfall to Avoid
The most dangerous error is discontinuing aspirin to prevent minor bleeding complications while exposing the patient to potentially fatal thromboembolic events. The cardiovascular indication for aspirin (prior MI, stroke, stent placement) carries far greater morbidity and mortality risk than any bleeding complication from cataract surgery. Studies show no difficulty achieving hemostasis even when minor bleeding occurs 5.
Practical Considerations
Modern cataract surgery techniques have evolved to be extremely low-risk procedures. The combination of topical anesthesia and clear corneal phacoemulsification makes continuation of antiplatelet therapy safe 4, 5. Survey data shows that the majority of experienced, high-volume cataract surgeons do not discontinue aspirin perioperatively 6.
The risk-benefit calculation strongly favors continuation: preventing one stroke or MI far outweighs managing subconjunctival hemorrhage in multiple patients.